Document is current
Any future updates will be listed below
-
Authors
Kidwell, Kelley M. https://orcid.org/0000-0002-1717-4483
Roychoudhury, Satrajit
Wendelberger, Barbara
Scott, John
Moroz, Tara
Yin, Shaoming
Majumder, Madhurima
Zhong, John
Huml, Raymond A.
Miller, Veronica
- License Information
-
More Information
Article History
Received: 9 December 2021
Accepted: 26 April 2022
First Online: 7 May 2022
Declarations
:
: Not applicable.
: Not applicable.
: Satrajit Roychoudhury is an employee and stock holder of Pfizer Inc. Barbara Wendelberger is an employee of Berry Consultants, LLC where she serves as a consultant to numerous pharmaceutical and device companies. Veronica Miller is an employee of the Forum for Collaborative Research (Forum). Over the last two years, the Forum has received unrestricted educational or research support from: Acer Therapeutics; Amicus Therapeutics; Biomarin Pharmaceutical; Global Blood Therapeutics; Horizon Therapeutics; Koneksa Health; Momenta Pharmaceuticals; Pfizer; PTC Therapeutics; RegenexBio; Solid Biosciences; and Travere Therapeutics. Raymond Huml is an employee and stock holder of Syneos Health and a member of the Drug Information Association Adaptive Design Working Group (DIA-ADSWG) subgroup on Master Protocols for use in rare diseases.
